Recent Finacing
Recent Raise
Quench Bio is a Cambridge-based biotechnology company developing Gasdermin D inhibitors that target pyroptosis and NETosis pathways to prevent release of inflammatory cytokines, alarmins, DNA, and NETs.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Quench Bio.
